Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pirfenidone
Related studies linked through entity extraction aliases.
Pirfenidone for Progressive Fibrotic Sarcoidosis
- Status
- UNKNOWN
- Phase
- PHASE4
Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
- Status
- COMPLETED
- Phase
- PHASE3
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
- Status
- COMPLETED
- Phase
- N/A
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE2
Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
- Status
- UNKNOWN
- Phase
- PHASE4
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- N/A
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
- Status
- COMPLETED
- Phase
- N/A